NASDAQ:DRVN
Driven Brands Holdings Inc. (NASDAQ: DRVN) Earnings Preview and Financial Challenges
Font: Financial Modeling Prep • Mar 03, 2026
Driven Brands Holdings Inc. (NASDAQ: DRVN) is a prominent player in the automotive services industry, offering a range of services including vehicle repair, maintenance, and car washes. The company had originally planned to release its fourth-quarter and full-year 2025 earnings on February 25, 2026. However, on February 25, 2026, Driven Brands announced that its Audit Committee had identified material errors in previously issued financial statements for fiscal years 2023 and 2024, as well as multiple interim periods in 2025. These statements can no longer be relied upon and require restatement. As a result, the Q4/full-year 2025 earnings release and conference call have been delayed (no new firm date has been confirmed by the company; Yahoo Finance currently lists an estimated date of March 4, 2026).
Pre-delay analyst consensus estimates were an EPS of $0.29 and revenue of approximately $458.6 million.The restatement announcement has triggered multiple law-firm investigations, including by Robbins Geller Rudman & Dowd LLP, for potential violations of U.S. federal securities laws. This development, combined with the delay and restatement, has significantly impacted investor confidence, especially for shareholders who have experienced financial losses. Several other firms have also launched similar inquiries.Financially, DRVN continues to navigate a complex landscape.
The company reports negative trailing-twelve-month (TTM) earnings (TTM diluted EPS of –$1.50 and net income available to common shareholders of –$234.34 million), confirming it is not currently profitable. Profit margin stands at –8.12%.DRVN’s valuation metrics present a mixed picture and have shifted following the recent ~20–30% stock-price decline after the restatement news (current price ~$11.17; market cap ~$1.84 billion):
- Price-to-sales (ttm) ratio of 0.74 (suggests the stock is valued below its annual sales).
- Enterprise value to sales ratio of 1.82 (enterprise value ~$4.43 billion).
- Enterprise value to operating cash flow ratio of approximately 16.55.
Market Overview
|
BRTX
BioRestorative Therapies, Inc.
|
$0.28
21.98%
|
|
SGN
Signing Day Sports, Inc.
|
$0.73
36.04%
|
|
LGVN
Longeveron Inc.
|
$1.06
100.25%
|
|
NIO
NIO Inc.
|
$5.47
10.77%
|
|
DXST
Decent Holding Inc.
|
$0.38
44.79%
|
|
VTAK
Catheter Precision, Inc.
|
$1.97
43.43%
|
|
HIMS
Hims & Hers Health, Inc.
|
$24.00
8.30%
|
|
HIMZ
Daily Target 2X Long HIMS ETF
|
$2.35
15.81%
|
|
RENX
RenX Enterprises Corp.
|
$0.13
-3.66%
|
|
SOXL
Direxion Daily Semiconductor Bull 3X ETF
|
$55.29
3.69%
|
